Delivery Order SPE2DB22D1106-SPE2DB24FEPB3
- Not listed
- This federal contract award is for the delivery of 10,000 units of PROCRIT (epoetin alfa) 10,000 units/mL vials to the Defense Logistics Agency (DLA). The $2,087.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, Corporate Office Division, a major pharmaceutical distributor. The contract does not have a set-aside designation and runs through July 1, 2024. Amerisourcebergen holds a single-award $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,026.26 firm fixed-price delivery order is for the supply of 40,000 units of PROCRIT 40,000 units/mL vials. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $5,820.40, is for the procurement of 4,565,153,154 units of PROCRIT 4,000 units/mL vials. The contract has an ultimate completion date of July 16, 2024 and is a firm fixed-price delivery order. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of PROCRIT 10,000 units/mL vials. The $2,464.38 Firm Fixed Price Delivery Order was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics and acquisition services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $1,029.56 firm fixed-price delivery order is for the supply of 10,000 units of PROCRIT (epoetin alfa) 10,000 units/mL vials. The award does not have a set-aside designation. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at up to...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,592.84 firm fixed-price contract is for the delivery of 40,000 units of the medication PROCRIT, a treatment for anemia, to fulfill federal medical supply requirements. The contract has a completion date of June 13, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,974.94 firm fixed price delivery order is for the supply of 40,000 units/mL of Procrit, a specialty medication. The contract has a completion date of November 24, 2023 and was awarded on November 22, 2023. This award appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
- This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of 20,000 units of the drug Procrit at $1,103.49. The award is a Delivery Order (DO) under an Indefinite Delivery Contract (IDC) held by the parent company, Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Cencora, Inc. to deliver a comprehensive range of...
- This federal contract award was made by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $16,784.99 delivery order is for the supply of 10,000 units/ml of the drug Procrit. This award does not have a set-aside designation. Amerisourcebergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with government agencies, including a $999,999,999 IDC with the DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of Procrit 10,000 units/ml vials valued at $5,089.52. This firm fixed-price delivery order is set to be completed by October 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a non-set-aside, competitively awarded contract, reflecting AmerisourceBergen's capability to meet federal pharmaceutical...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEPB3Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 20,000 units of PROCRIT 20,000 units/mL vial medication. The $4,210.78 firm-fixed-price contract was awarded on April 29, 2024 by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 30, 2024. The contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical that serves as the primary vehicle for delivering a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller $750,000 Indefinite Delivery Contract with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 4/29/24 |